Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Van Aken, H; Bode, C; Darius, H; Diehm, C; Encke, M; Gulba, DC; Haas, S; Hacke, W; Puhl, W; Quante, M; Riess, H; Scharf, R; Schellong, S; Schror, K; Schulte, KL; Tebbe, U
   Anticoagulation: The present and future
   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
   
   H. Van Aken et al., "Anticoagulation: The present and future", CL APPL T-H, 7(3), 2001, pp. 195-204
2. Moser, M; Ruef, J; Peter, K; Kohler, B; Gulba, DC; Paterna, N; Nordt, T; Kubler, W; Bode, C
   Ecarin clotting time but not aPTT correlates with PEG-Hirudin plasma activity
   JOURNAL OF THROMBOSIS AND THROMBOLYSIS
   
   M. Moser et al., "Ecarin clotting time but not aPTT correlates with PEG-Hirudin plasma activity", J THROMB TH, 12(2), 2001, pp. 165-169
3. Lankes, W; Fleischer, K; Gulba, DC
   Direct thrombin inhibitors
   HERZ
   
   W. Lankes et al., "Direct thrombin inhibitors", HERZ, 26, 2001, pp. 46-52
4. Kusch, A; Gulba, DC
   Impact and signal transduction of the uPA/uPAR system in arteriosclerosis and restenosis
   ZEITSCHRIFT FUR KARDIOLOGIE
   
   A. Kusch e D.C. Gulba, "Impact and signal transduction of the uPA/uPAR system in arteriosclerosis and restenosis", Z KARDIOL, 90(5), 2001, pp. 307
5. Agnelli, G; Avezum, A; Brieger, D; Budaj, A; Cannon, CP; Goldberg, RJ; Goodman, S; Gulba, DC; Granger, C; Kennelly, BM; Gurfinkel, E; Lopez-Sendon, J; Klein, W; Montalescot, G; Van de Werf, F
   Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: A multinational registry of patients hospitalized with acute coronary syndromes
   AMERICAN HEART JOURNAL
   
   G. Agnelli et al., "Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: A multinational registry of patients hospitalized with acute coronary syndromes", AM HEART J, 141(2), 2001, pp. 190-199
6. Gulba, DC; Eichstadt, H; Engberding, R; Schulze, MR; Struppler, M; Rutsch, W
   Suggested revisions to the current guidelines for the diagnosis and treatment of unstable angina and non-q-wave myocardial infarction by the International Cardiology Forum (ICF) of 1998
   ZEITSCHRIFT FUR KARDIOLOGIE
   
   D.C. Gulba et al., "Suggested revisions to the current guidelines for the diagnosis and treatment of unstable angina and non-q-wave myocardial infarction by the International Cardiology Forum (ICF) of 1998", Z KARDIOL, 89(8), 2000, pp. 708-723
7. Kusch, A; Tkachuk, S; Haller, H; Dietz, R; Gulba, DC; Lipp, M; Dumler, I
   Urokinase stimulates human vascular smooth muscle cell migration via a phosphatidylinositol 3-kinase-Tyk2 interaction
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   A. Kusch et al., "Urokinase stimulates human vascular smooth muscle cell migration via a phosphatidylinositol 3-kinase-Tyk2 interaction", J BIOL CHEM, 275(50), 2000, pp. 39466-39473
8. Dechend, R; Homuth, V; Wallukat, G; Kreuzer, J; Park, JK; Theuer, J; Juepner, A; Gulba, DC; Mackman, N; Haller, H; Luft, FC
   AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor
   CIRCULATION
   
   R. Dechend et al., "AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor", CIRCULATION, 101(20), 2000, pp. 2382-2387
9. Dumler, I; Kopmann, A; Weis, A; Mayboroda, OA; Wagner, K; Gulba, DC; Haller, H
   Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells
   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
   
   I. Dumler et al., "Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells", ART THROM V, 19(2), 1999, pp. 290-297
10. Dumler, I; Stepanova, V; Jerke, U; Mayboroda, OA; Vogel, F; Bouvet, P; Tkachuk, V; Haller, H; Gulba, DC
    Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin
    CURRENT BIOLOGY
    
    I. Dumler et al., "Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin", CURR BIOL, 9(24), 1999, pp. 1468-1476
11. Gulba, DC
    Do interventions provide additional benefit to drug treatment of acute coronary syndromes? A call for a reserved, watchful approach
    THROMBOSIS AND HAEMOSTASIS
    
    D.C. Gulba, "Do interventions provide additional benefit to drug treatment of acute coronary syndromes? A call for a reserved, watchful approach", THROMB HAEM, 82(2), 1999, pp. 953-961
12. Dumler, I; Kopmann, A; Wagner, K; Mayboroda, OA; Jerke, U; Dietz, R; Haller, H; Gulba, DC
    Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    I. Dumler et al., "Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells", J BIOL CHEM, 274(34), 1999, pp. 24059-24065
13. Christow, SP; Bychkov, R; Schroeder, C; Dietz, R; Haller, H; Dumler, I; Gulba, DC
    Urokinase activates calcium-dependent potassium channels in U937 cells viacalcium release from intracellular stores
    EUROPEAN JOURNAL OF BIOCHEMISTRY
    
    S.P. Christow et al., "Urokinase activates calcium-dependent potassium channels in U937 cells viacalcium release from intracellular stores", EUR J BIOCH, 265(1), 1999, pp. 264-272
14. Dechend, R; Maass, M; Gieffers, J; Dietz, R; Scheidereit, C; Leutz, A; Gulba, DC
    Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappa B and induces tissue factor and PAI-1 expression - A potential link to accelerated arteriosclerosis
    CIRCULATION
    
    R. Dechend et al., "Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappa B and induces tissue factor and PAI-1 expression - A potential link to accelerated arteriosclerosis", CIRCULATION, 100(13), 1999, pp. 1369-1373
15. GULBA DC; HUBER K; MOLL S; DIETZ R
    PLATELET INHIBITION - NEW AGENTS, NEW STRATEGIES, NEW TRIALS
    FIBRINOLYSIS & PROTEOLYSIS
    
    D.C. Gulba et al., "PLATELET INHIBITION - NEW AGENTS, NEW STRATEGIES, NEW TRIALS", FIBRINOLYSIS & PROTEOLYSIS, 12, 1998, pp. 13-23
16. GULBA DC; BODE C; RUNGE MS; HUBER K
    THROMBOLYTIC AGENTS - AN UPDATED OVERVIEW
    FIBRINOLYSIS & PROTEOLYSIS
    
    D.C. Gulba et al., "THROMBOLYTIC AGENTS - AN UPDATED OVERVIEW", FIBRINOLYSIS & PROTEOLYSIS, 12, 1998, pp. 39-58
17. DUMLER I; WEIS A; MAYBORODA OA; MAASCH C; JERKE U; HALLER H; GULBA DC
    THE JAK STAT PATHWAY AND UROKINASE RECEPTOR SIGNALING INHUMAN AORTIC VASCULAR SMOOTH-MUSCLE CELLS/
    The Journal of biological chemistry
    
    I. Dumler et al., "THE JAK STAT PATHWAY AND UROKINASE RECEPTOR SIGNALING INHUMAN AORTIC VASCULAR SMOOTH-MUSCLE CELLS/", The Journal of biological chemistry, 273(1), 1998, pp. 315-321
18. GULBA DC; PRAUS M; DECHEND R; HAUCK S; MAHLER M; ZITVZ R; BALDUS B; MULLER W; DIETZ R
    UPDATE ON THE TOXICOLOGY AND PHARMACOLOGY OF RDSPA ALPHA-1 (BAT-PA) IN ANIMALS AND HUMANS
    Fibrinolysis & proteolysis
    
    D.C. Gulba et al., "UPDATE ON THE TOXICOLOGY AND PHARMACOLOGY OF RDSPA ALPHA-1 (BAT-PA) IN ANIMALS AND HUMANS", Fibrinolysis & proteolysis, 11, 1997, pp. 55-62
19. WINDSTETTER U; HUBER K; GULBA DC
    NEW ANTITHROMBOTIC AGENTS - AN OVERVIEW
    Fibrinolysis & proteolysis
    
    U. Windstetter et al., "NEW ANTITHROMBOTIC AGENTS - AN OVERVIEW", Fibrinolysis & proteolysis, 11, 1997, pp. 85-96
20. GULBA DC; TANSWELL P; DECHEND R; SOSADA M; WEIS A; WAIGAND J; UHLICH F; HAUCK S; JOST S; RAFFLENBEUL W; LICHTLEN PR; DIETZ R
    60-MINUTE ALTEPLASE PROTOCOL - A NEW ACCELERATED RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR REGIMEN FOR THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION
    Journal of the American College of Cardiology
    
    D.C. Gulba et al., "60-MINUTE ALTEPLASE PROTOCOL - A NEW ACCELERATED RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR REGIMEN FOR THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION", Journal of the American College of Cardiology, 30(7), 1997, pp. 1611-1617
21. WEIS A; DUMLER I; DIETZ R; GULBA DC
    INVOLVEMENT OF JANUS KINASES (JAK) IN UROKINASE RECEPTOR (UPAR) SIGNALING - A NOVEL PATHWAY TO ALTER GENE-EXPRESSION IN THE DEVELOPMENT OF ATHEROSCLEROSIS
    Journal of the American College of Cardiology
    
    A. Weis et al., "INVOLVEMENT OF JANUS KINASES (JAK) IN UROKINASE RECEPTOR (UPAR) SIGNALING - A NOVEL PATHWAY TO ALTER GENE-EXPRESSION IN THE DEVELOPMENT OF ATHEROSCLEROSIS", Journal of the American College of Cardiology, 29(2), 1997, pp. 41143-41143
22. GROSS CM; KRAMER J; WAIGAND J; UHLICH F; SCHRODER G; THALHAMMER C; DECHEND R; GULBA DC; DIETZ R
    STENT IMPLANTATION IN PATIENTS WITH SUPERIOR VENA-CAVA SYNDROME
    American journal of roentgenology
    
    C.M. Gross et al., "STENT IMPLANTATION IN PATIENTS WITH SUPERIOR VENA-CAVA SYNDROME", American journal of roentgenology, 169(2), 1997, pp. 429-432
23. DUMLER I; WELS A; HALLER H; GULBA DC
    JANUS KINASES ARE INVOLVED IN UROKINASE RECEPTOR SIGNALING IN MIGRATING VASCULAR SMOOTH-MUSCLE CELLS AFTER INJURY IN-VITRO
    Thrombosis and haemostasis
    
    I. Dumler et al., "JANUS KINASES ARE INVOLVED IN UROKINASE RECEPTOR SIGNALING IN MIGRATING VASCULAR SMOOTH-MUSCLE CELLS AFTER INJURY IN-VITRO", Thrombosis and haemostasis, 1997, pp. 2317-2317
24. DIETZ R; WAIGAND J; UHLICH F; OSTERZIEL KJ; GULBA DC
    STENTS - WHERE ARE WE GOING
    Zeitschrift fur Kardiologie
    
    R. Dietz et al., "STENTS - WHERE ARE WE GOING", Zeitschrift fur Kardiologie, 86(2), 1997, pp. 65-70
25. VANDERWERF F; VAHANIAN A; GULBA DC; MULLER J; ARNOLD AER; BAR F; VERMEER F; VERHEUGT FWA; BOERSMA H; VANES GA; DECKERS JW; LENDERINK T; SIMOONS ML; STEYERBERG E; VANDERZWAAN C; DEBOER MJ; ZIJLSTRA F; WILCOX RD; SLEIGHT P; SELKER HP; CALIFF RM; GRANGER C; LEE KL; OHMAN ME; WEAVER DW; LOVE T; WHITE H; CALIFF R; COLLINS R
    SELECTION OF REPERFUSION THERAPY FOR INDIVIDUAL PATIENTS WITH EVOLVING MYOCARDIAL-INFARCTION
    European heart journal
    
    F. Vanderwerf et al., "SELECTION OF REPERFUSION THERAPY FOR INDIVIDUAL PATIENTS WITH EVOLVING MYOCARDIAL-INFARCTION", European heart journal, 18(9), 1997, pp. 1371-1381
26. DUMLER I; WEIS A; JERKE U; HALLER H; GULBA DC
    SIGNAL-TRANSDUCTION VIA UROKINASE RECEPTOR IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS
    Atherosclerosis
    
    I. Dumler et al., "SIGNAL-TRANSDUCTION VIA UROKINASE RECEPTOR IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS", Atherosclerosis, 134(1-2), 1997, pp. 250-250
27. GULBA DC; WEIS A; DIETZ R; HALLER H; DUMLER I
    TRANSCRIPTIONAL REGULATION BY THE UROKINASE RECEPTOR-A ROLE FOR THE JAK STAT INTRACELLULAR SIGNALING MACHINERY/
    Circulation
    
    D.C. Gulba et al., "TRANSCRIPTIONAL REGULATION BY THE UROKINASE RECEPTOR-A ROLE FOR THE JAK STAT INTRACELLULAR SIGNALING MACHINERY/", Circulation, 96(8), 1997, pp. 200-200
28. GULBA DC; JERKE U; DIETZ R; HALLER H; DUMLER I
    IS THE REGULATION OF VSMCS VIA THE UROKINASE RECEPTOR-MEDIATED BY THEINTERACTION WITH B-3 INTEGRINS
    Circulation
    
    D.C. Gulba et al., "IS THE REGULATION OF VSMCS VIA THE UROKINASE RECEPTOR-MEDIATED BY THEINTERACTION WITH B-3 INTEGRINS", Circulation, 96(8), 1997, pp. 618-618
29. GULBA DC; BODE C; RUNGE MS; HUBER K
    THROMBOLYTIC AGENTS - AN OVERVIEW
    Annals of hematology
    
    D.C. Gulba et al., "THROMBOLYTIC AGENTS - AN OVERVIEW", Annals of hematology, 73, 1996, pp. 9-27
30. GULBA DC
    ANTICOAGULANT DRUGS
    Herz
    
    D.C. Gulba, "ANTICOAGULANT DRUGS", Herz, 21(1), 1996, pp. 12-27
31. DECHEND R; MO X; SCHULZ W; GROSS M; PRAUS M; DIETZ R; GULBA DC
    THROMBIN RECEPTOR AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR ARE COLOCALIZED IN VASCULAR SMOOTH-MUSCLE CELLS DERIVED FROM HUMAN CAROTID ATHEROSCLEROTIC PLAQUES
    Fibrinolysis
    
    R. Dechend et al., "THROMBIN RECEPTOR AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR ARE COLOCALIZED IN VASCULAR SMOOTH-MUSCLE CELLS DERIVED FROM HUMAN CAROTID ATHEROSCLEROTIC PLAQUES", Fibrinolysis, 10, 1996, pp. 41-45
32. GULBA DC
    BIOCHEMICAL, PHARMACOLOGICAL AND CLINICAL PROPERTIES OF RECENT THROMBOLYTIC AGENTS (VOL 37, PG 552, 1996)
    Der Internist
    
    D.C. Gulba, "BIOCHEMICAL, PHARMACOLOGICAL AND CLINICAL PROPERTIES OF RECENT THROMBOLYTIC AGENTS (VOL 37, PG 552, 1996)", Der Internist, 37(7), 1996, pp. 704-704
33. GULBA DC
    BIOCHEMICAL, PHARMACOLOGICAL AND CLINICAL PROPERTIES OF RECENT THROMBOLYTIC AGENTS
    Der Internist
    
    D.C. Gulba, "BIOCHEMICAL, PHARMACOLOGICAL AND CLINICAL PROPERTIES OF RECENT THROMBOLYTIC AGENTS", Der Internist, 37(6), 1996, pp. 552-566
34. GULBA DC; GROSS M; DECHEND R; LUFT F; SOSADA M; FREY U; DIETZ R
    THROMBOLYTIC THERAPY IN RENAL ARTERIAL EM BOLISM - CASE-REPORT WITH LITERATURE-REVIEW
    Der Internist
    
    D.C. Gulba et al., "THROMBOLYTIC THERAPY IN RENAL ARTERIAL EM BOLISM - CASE-REPORT WITH LITERATURE-REVIEW", Der Internist, 37(6), 1996, pp. 623-627
35. WAIGAND J; UHLICH F; GULBA DC; GROSS M; DIETZ R
    INTRACORONARY STENTING WITH THE MULTILINK STENT - SINGLE-CENTER EXPERIENCE
    Circulation
    
    J. Waigand et al., "INTRACORONARY STENTING WITH THE MULTILINK STENT - SINGLE-CENTER EXPERIENCE", Circulation, 94(8), 1996, pp. 506-506
36. MO XM; DECHEND R; KOWENZLEUTZ E; DIETZ R; LEUTZ A; GULBA DC
    DOSE-DEPENDENT INHIBITION OF APOPTOSIS OF HUMAN AORTIC SMOOTH-MUSCLE CELLS (HASMC) BY ANTIOXIDANTS
    Circulation
    
    X.M. Mo et al., "DOSE-DEPENDENT INHIBITION OF APOPTOSIS OF HUMAN AORTIC SMOOTH-MUSCLE CELLS (HASMC) BY ANTIOXIDANTS", Circulation, 94(8), 1996, pp. 905-905
37. DUMLER I; CHRISTOW S; WEIS A; KRENTLER J; GULBA DC
    UROKINASE-TYPE PLASMINOGEN ACTIVATOR-INDUCED TRANSMEMBRANE SIGNALING,AN IMPORTANT CONTRIBUTOR TO HUMAN AORTIC SMOOTH-MUSCLE CELL-GROWTH
    Circulation
    
    I. Dumler et al., "UROKINASE-TYPE PLASMINOGEN ACTIVATOR-INDUCED TRANSMEMBRANE SIGNALING,AN IMPORTANT CONTRIBUTOR TO HUMAN AORTIC SMOOTH-MUSCLE CELL-GROWTH", Circulation, 94(8), 1996, pp. 2724-2724
38. FRIEDRICH MG; DECHEND R; BARKOWSKI A; JUNGNICKEL K; BACHER P; WELZEL D; DIETZ R; GULBA DC
    PREVENTION OF RESTENOSIS AFTER PTCA WITH LONG-TERM TREATMENT OF LOW-MOLECULAR-WEIGHT HEPARIN - RESULTS OF A PILOT-STUDY
    Thrombosis and haemostasis
    
    M.G. Friedrich et al., "PREVENTION OF RESTENOSIS AFTER PTCA WITH LONG-TERM TREATMENT OF LOW-MOLECULAR-WEIGHT HEPARIN - RESULTS OF A PILOT-STUDY", Thrombosis and haemostasis, 73(6), 1995, pp. 981-981
39. DECHEND R; SELBIG D; PRAUS M; HAUCK S; DIETZ R; GULBA DC
    LONG-TERM THROMBOLYTIC THERAPY WITH 2 NEW RT-PA REGIMEN IN SUBMASSIVEPULMONARY-EMBOLISM - RESULTS OF A PILOT-STUDY
    Thrombosis and haemostasis
    
    R. Dechend et al., "LONG-TERM THROMBOLYTIC THERAPY WITH 2 NEW RT-PA REGIMEN IN SUBMASSIVEPULMONARY-EMBOLISM - RESULTS OF A PILOT-STUDY", Thrombosis and haemostasis, 73(6), 1995, pp. 1108-1108
40. GULBA DC; DECHEND R; FRIEDRICH MG; FRIEDRICH M; DIETZ R; LUFT FC
    THROMBOLYTIC THERAPY IN RENAL ARTERIAL EMBOLISM
    Thrombosis and haemostasis
    
    D.C. Gulba et al., "THROMBOLYTIC THERAPY IN RENAL ARTERIAL EMBOLISM", Thrombosis and haemostasis, 73(6), 1995, pp. 1328-1328
41. HUBER K; BODE C; GULBA DC
    THROMBOLYSIS - A RAPIDLY MOVING TARGET OF ANTITHROMBOTIC THERAPY - A PREFACE
    Fibrinolysis
    
    K. Huber et al., "THROMBOLYSIS - A RAPIDLY MOVING TARGET OF ANTITHROMBOTIC THERAPY - A PREFACE", Fibrinolysis, 9, 1995, pp. 1-2
42. DECHEND R; GULBA DC; HAUCK S; DIETZ R
    THE PROBLEM OF REOCCLUSION AND RESTENOSIS - CLINICAL ASPECTS
    Fibrinolysis
    
    R. Dechend et al., "THE PROBLEM OF REOCCLUSION AND RESTENOSIS - CLINICAL ASPECTS", Fibrinolysis, 9, 1995, pp. 48-52
43. GULBA DC; PRAUS M; WITT W
    DSPA-ALPHA - PROPERTIES OF THE PLASMINOGEN ACTIVATORS OF THE VAMPIRE BAT DESMODUS-ROTUNDUS
    Fibrinolysis
    
    D.C. Gulba et al., "DSPA-ALPHA - PROPERTIES OF THE PLASMINOGEN ACTIVATORS OF THE VAMPIRE BAT DESMODUS-ROTUNDUS", Fibrinolysis, 9, 1995, pp. 91-96
44. HAUCK S; FRIEDRICH M; DECHEND R; GULBA DC; DIETZ R
    CONTINUOUS 3-DIMENSIONAL VECTORCARDIOGRAPHY, A VALUABLE TOOL FOR ONLINE ISCHEMIA MONITORING
    Fibrinolysis
    
    S. Hauck et al., "CONTINUOUS 3-DIMENSIONAL VECTORCARDIOGRAPHY, A VALUABLE TOOL FOR ONLINE ISCHEMIA MONITORING", Fibrinolysis, 9, 1995, pp. 114-120
45. GULBA DC; WAIGAND J; OSTERZIEL KJ; DIETZ R
    RISK ASSESSMENT AND SECONDARY PREVENTION FOLLOWING PTCA AND BYPASS-SURGERY
    Der Internist
    
    D.C. Gulba et al., "RISK ASSESSMENT AND SECONDARY PREVENTION FOLLOWING PTCA AND BYPASS-SURGERY", Der Internist, 36(9), 1995, pp. 891-901
46. PRAUS M; MO XM; GROSSE Y; BALDUS B; MORSER J; DECHEND R; GULBA DC
    A NOVEL THROMBOMODULIN BASED PLASMA ASSAY UNCOVERS ABNORMALITIES IN THE PROTEIN-S PROTEIN-C ANTICOAGULANT PATHWAY DISTINCT FROM RESISTANCE TO ACTIVATED PROTEIN-C IN MYOCARDIAL-INFARCTION PATIENTS
    Circulation
    
    M. Praus et al., "A NOVEL THROMBOMODULIN BASED PLASMA ASSAY UNCOVERS ABNORMALITIES IN THE PROTEIN-S PROTEIN-C ANTICOAGULANT PATHWAY DISTINCT FROM RESISTANCE TO ACTIVATED PROTEIN-C IN MYOCARDIAL-INFARCTION PATIENTS", Circulation, 92(8), 1995, pp. 2989-2989
47. GULBA DC; DECHEND R
    THROMBOLYSIS IN THROMBOEMBOLIC DISEASES
    Annals of hematology
    
    D.C. Gulba e R. Dechend, "THROMBOLYSIS IN THROMBOEMBOLIC DISEASES", Annals of hematology, 69(4), 1994, pp. 190000041-190000057
48. DECHEND R; HAUCK S; EICHHORN J; GOEDECKE W; PRAUS M; SCHULZMENGER J; BARTHELS M; DIETZ R; GULBA DC
    EFFECTS OF LOW-MOLECULAR-WEIGHT AND HIGH-MOLECULAR-WEIGHT HEPARIN ON THE INTRINSIC AND EXTRINSIC ENDOGENOUS FIBRINOLYTIC SYSTEM
    Fibrinolysis
    
    R. Dechend et al., "EFFECTS OF LOW-MOLECULAR-WEIGHT AND HIGH-MOLECULAR-WEIGHT HEPARIN ON THE INTRINSIC AND EXTRINSIC ENDOGENOUS FIBRINOLYTIC SYSTEM", Fibrinolysis, 8, 1994, pp. 71-74
49. DECHEND R; THODE H; MULLER T; EISERT WE; DIETZ R; GULBA DC
    FRAGMENTATION-PATTERN OF FIBRINOGEN DURING THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION WITH FIBRIN-SPECIFIC PLASMINOGEN ACTIVATORS - DETECTION OF HIGH-MOLECULAR-WEIGHT FIBRINOGEN DEGRADATION PRODUCTS
    Fibrinolysis
    
    R. Dechend et al., "FRAGMENTATION-PATTERN OF FIBRINOGEN DURING THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION WITH FIBRIN-SPECIFIC PLASMINOGEN ACTIVATORS - DETECTION OF HIGH-MOLECULAR-WEIGHT FIBRINOGEN DEGRADATION PRODUCTS", Fibrinolysis, 8, 1994, pp. 102-104
50. GULBA DC; SCHMID C; BORST HG; LICHTLEN P; DIETZ R; LUFT FC
    MEDICAL COMPARED WITH SURGICAL-TREATMENT FOR MASSIVE PULMONARY-EMBOLISM
    Lancet
    
    D.C. Gulba et al., "MEDICAL COMPARED WITH SURGICAL-TREATMENT FOR MASSIVE PULMONARY-EMBOLISM", Lancet, 343(8897), 1994, pp. 576-577
51. GULBA DC; BODE C
    THROMBOLYTIC THERAPY - INTRODUCTION
    Zeitschrift fur Kardiologie
    
    D.C. Gulba e C. Bode, "THROMBOLYTIC THERAPY - INTRODUCTION", Zeitschrift fur Kardiologie, 82, 1993, pp. 1-2
52. GULBA DC
    THROMBOLYTIC THERAPY IN PULMONARY-EMBOLIS M - A THERAPEUTIC OPTION
    Zeitschrift fur Kardiologie
    
    D.C. Gulba, "THROMBOLYTIC THERAPY IN PULMONARY-EMBOLIS M - A THERAPEUTIC OPTION", Zeitschrift fur Kardiologie, 82, 1993, pp. 29-34
53. GULBA DC
    THE IMPACT OF LATE REPERFUSION ON INFARCT SURVIVAL
    Zeitschrift fur Kardiologie
    
    D.C. Gulba, "THE IMPACT OF LATE REPERFUSION ON INFARCT SURVIVAL", Zeitschrift fur Kardiologie, 82, 1993, pp. 183-185